- Anecdotal reports from patients.
- Robust evidence of efficacy and safety from Phase III clinical trials.
- Only pre-clinical animal studies.
- Opinions from key opinion leaders.
48. A drug manufacturer submits a New Drug Application (NDA) to a regulatory agency. What medicinal epidemiological evidence is critically required to support this application?
Facebook
WhatsApp
